Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine.Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.Read More: http://informahealthcare.com/page/phb/Description.
More than 40 years in publication through 2007, the monthly Pharmaceutical Chemistry Journal is devoted to scientific and technical research on the creation of new drugs and the improvement of manufacturing technology of drugs and intermediates. International contributors cover the entire spectrum of new drug research, including methods of synthesis; results of pharmacological, toxicological, and biochemical studies; investigation of structure - activity relationships in prediction of new compounds; methods and technical facilities used; and problems associated with the development of ecologically safe and economically feasible methods of industrial production. In addition, analytical reviews of international literature in the field report on recent developments around the world. Pharmaceutical Chemistry Journal is a translation of the peer-reviewed Russian journal Khimiko-Farmatsevticheskii Zhurnal.
Pharmaceutical Development and Technology publishes research in the design, development, manufacture, and evaluation of traditional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems.Through basic and applied research articles, review papers, short reports, and book reviews, Pharmaceutical Development and Technology covers topics such as: *Preformulation evaluation of pharmaceutical materials *Physical pharmacy and formulation *Research process engineering and scale-up of drug delivery systems *Drug delivery systems evaluation and quality improvement *Global standardization of pharmaceutical information.
Pharmaceutical Fronts is an international peer-reviewed journal focusing on the rapid and high-quality dissemination of the latest breakthroughs in pharmaceutical development across major scientific and engineering disciplines. It is an affiliated journal of the Chinese Journal of Pharmaceuticals (EI Compendex), which was founded in 1970, and sponsored by Shanghai Institute of Pharmaceutical Industry, Chinese Pharmaceutical Association and China Pharmaceutical Industry Association. The journal is delivering the ultimate reader experience with an innovative manuscript acquisition and review process focusing on information density, utility, and reliability. Its aims to cover original research as well as high quality reviews in medicinal chemistry, process development, and technological innovations for both laboratory and production settings. We will remain agile towards reader feedback and seek to provide a unique service to the global scientific and industrial community in the quest for better medicines and better ways to make them for patients across the world.
Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others. Pharmaceutical Research publishes twelve issues a year.
Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers. The aims of the Journal are to: